HOME Top Market Reports Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021

Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: March 2016
Report Code: BT 2697

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The Next Generation Sequencing market is expected to reach USD 10,371.1 Million by 2021 from USD 4,031.7 Million in 2016, at a CAGR of 20.8%. Next-generation sequencing refers to non-Sanger-based high-throughput DNA sequencing technologies. Millions or billions of DNA strands can be sequenced in parallel, yielding substantially more throughput and minimizing the need for the fragment-cloning methods that are often used in Sanger sequencing of genomes. The ability to sequence DNA opened up abundant application avenues for NGS technologies in scientific research including personalized medicine, cancer research, drug discovery, biomarker discovery, and agricultural & animal sciences.

The major drivers for the NGS market include the technological advancements in NGS products, increasing applications of NGS, entry of new market players, and increasing partnerships & collaborations among market players as well as growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders.

This report broadly segments the global NGS market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The pre-sequencing products & services segment if further categorized into DNA fragmentation. End repair, A-tailing, & size selection; library preparation & target enrichment; and quality control. The NGS platforms segment is sub-segmented into HiSeq Series, MiSeq Series, HiSeq X Ten & X Five, NextSeq500, Ion PGM, ION Proton, Ion S5 & S5 XL, PacBioRS II, and Sequel System. Based on applications, the sequencing services market is segmented into targeted sequencing, whole-genome sequencing, exome sequencing, RNA-Seq, De novo sequencing, Methyl-Seq, and ChiP-seq.

The technologies for next generation sequencing market include sequencing by synthesis (SBS), ion semiconductor sequencing, sequencing by ligation (SBL), pyrosequencing, and single-molecule real-time (SMRT) sequencing. The end users of NGS market include research centers & academic/government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others (non-profit organizations & agrigenomics organizations).

Based on region, the next generation sequencing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The major players in the global next generation sequencing market are Illumina, Inc. (U.S.); Thermo Fisher Scientific, Inc. (U.S.); Pacific Biosciences of California, Inc. (U.S.); Roche Holding AG (Switzerland); QIAGEN N. V. (Germany); BGI (China), Macrogen Inc. (South Korea); Eurofins Scientific (Luxembourg); and Oxford Nanopore Technologies, Ltd. (U.K.).

Scope of the Report

This report categorizes the global next generation sequencing market into the following segments:

Global Next-generation Sequencing Market (NGS), by Products and Services

  • Pre-sequencing Products and Services
    • DNA Fragmentation and Size Selection
    • Library Preparation & Target Enrichment
    • Quality Control
  • NGS Platforms, Consumables/Reagents, and Services
    • Illumina
      • HiSeq Series
      • HiSeq X Ten & HiSeq X Five
      • MiSeq Series
      • NextSeq 500
    • Life Technologies (Thermo Fisher)
      • SOLiD Series
      • Ion PGM (Personal Genome Machine)
      • Ion Proton
      • Ion S5 & Ion S5 XL
    • Pacific Biosciences
      • PacBio RS II
      • Sequel System
    • Other Platforms
  • Sequencing Services
  • NGS Data Analysis/Bioinformatics
    • By Product
      • NGS Data Analysis Software and Workbenches
      • NGS Data Analysis Services
      • NGS Storage Management and Cloud Computing Solutions
    • By Application
      • Whole-genome Sequencing
      • Exome Sequencing
      • Targeted Resequencing
      • De Novo Sequencing
      • RNA Sequencing
      • ChIP Sequencing
      • Methyl Sequencing
      • Others

Global next generation sequencing Market, by Technology

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation (SBL)
  • Pyrosequencing
  • Single-Molecule Real-time (SMRT) Sequencing
  • Other Technologies

Global next generation sequencing Market, by Application

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture and Animal Research
  • Others

Global next generation sequencing Market, by End User

  • Research Centers & Academic/Government Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Global next generation sequencing Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary (Page No. - 32)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 36)
    4.1 Global NGS Market (2016–2021)
    4.2 Global NGS Market Share, By Products & Services (2016 vs 2021)
    4.3 NGS Sequencing Services Market, By Applications (2016 vs 2021)
    4.4 Global NGS Technology Market Size, By Region  (2016-2021)

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Products & Services
           5.2.2 By Technology
           5.2.3 By Application
           5.2.4 By End User
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Technological Advancements in Sequencing Platforms
                    5.3.1.2 Increasing Applications of NGS
                    5.3.1.3 Growing Partnerships and Collaborations
                    5.3.1.4 Research Laboratories and Academicians Promoting NGS
                    5.3.1.5 Entry of New Market Players
                    5.3.1.6 Conferences and Workshops Increasing Awareness on NGS Products and Services
           5.3.2 Restraints
                    5.3.2.1 Accuracy & Standardization Concerns in Diagnostic Testing
                    5.3.2.2 Lack of Skilled Professionals
                    5.3.2.3 Ethical and Legal Issues Related to NGS
           5.3.3 Opportunities
                    5.3.3.1 Personalized Medicine & Biomarker Discovery Open Avenues for the Growth of Next Generation Sequencing Market
                    5.3.3.2 Emerging Markets Offer Numerous Growth Opportunities
                    5.3.3.3 Cloud Computing, A Prospective Service
           5.3.4 Challenges
                    5.3.4.1 Interpretation of Complex Data From NGS Platforms
                    5.3.4.2 Storage of Sequencing Data
           5.3.5 Current Trends
                    5.3.5.1 Development of New and Advanced NGS Platforms
                    5.3.5.2 Focus on Cancer Research
                    5.3.5.3 Mergers and Acquisitions

6  Global Next Generation Sequencing Market, By Products & Services (Page No. - 55)
    6.1 Introduction
    6.2 Pre-Sequencing Products & Services
           6.2.1 Sample Preparation
                    6.2.1.1 DNA Fragmentation, End Repair, A-Tailing, and Size Selection
                    6.2.1.2 Library Preparation & Target Enrichment
                    6.2.1.3 Quality Control
    6.3 NGS Platforms, Consumables, & Services for Platforms
           6.3.1 NGS Platforms Market
                    6.3.1.1 Illumina
                               6.3.1.1.1 Hiseq Series
                               6.3.1.1.2 Hiseq X Ten & Hiseq X Five
                               6.3.1.1.3 Miseq Series
                               6.3.1.1.4 Nextseq500
                    6.3.1.2 Thermo Fisher Scientific (Life Technologies)
                               6.3.1.2.1 Solid Series
                               6.3.1.2.2 ION Torrent Platforms
                                             6.3.1.2.2.1 ION PGM
                                             6.3.1.2.2.2 ION Proton
                                             6.3.1.2.2.3 ION S5 & S5 Xl
                    6.3.1.3 Pacific Biosciences
                               6.3.1.3.1 Pacbio Rs Ii
                               6.3.1.3.2 Sequel System
                    6.3.1.4 Recently Launched Sequencing Platforms
    6.4 Sequencing Services
           6.4.1 Targeted Re-Sequencing
           6.4.2 RNA-Seq
           6.4.3 De Novo Sequencing
           6.4.4 Exome Sequencing
           6.4.5 Chip-Seq
           6.4.6 Whole-Genome Sequencing
           6.4.7 Methyl-Seq
           6.4.8 Others
    6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
           6.5.1 NGS Data Analysis Software & Workbenches
           6.5.2 NGS Data Analysis Services
           6.5.3 NGS Storage, Management, and Cloud Computing Solutions

7 Global Next-Generation Sequencing Market, By Technology (Page No. - 85)
    7.1 Introduction
    7.2 Sequencing By Synthesis (SBS)
    7.3 ION Semiconductor Sequencing
    7.4 Sequencing By Ligation (SBL)
    7.5 Pyrosequencing
    7.6 Single-Molecule Real-Time Sequencing (SMRT)
    7.7 Other Technologies

8 Global Next Generation Sequencing Market, By Application (Page No. - 93)
    8.1 Introduction
    8.2 Diagnostics
    8.3 Drug Discovery
    8.4 Biomarker Discovery
    8.5 Personalized Medicine
    8.6 Agriculture & Animal Research
    8.7 Other Applications

9 Next-Generation Sequencing Market, By End User (Page No. - 102)
    9.1 Introduction
           9.1.1 Research Centers and Academic & Government Institutes
           9.1.2 Hospitals & Clinics
           9.1.3 Pharmaceutical & Biotechnology Companies
           9.1.4 Other End-Users (NPO, Agrigenomics Organizations, Consumer Genomic Companies)

10 Next Generation Sequencing Market, By Region (Page No. - 108)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Favorable Government Funding Scenario in the U.S. Market
                        10.2.1.2 Growing Focus of Next Generation Sequencing Market Players on Strengthening Their Presence in the U.S.
                        10.2.1.3 Increasing Number of Next Generation Sequencing Conferences in the U.S.
                        10.2.1.4 Increasing Focus of Laboratories to Obtain Clia Certification
             10.2.2 Canada
                        10.2.2.1 Favorable Government Funding Scenario in Canada
                        10.2.2.2 Growing Focus of Market Players on Expanding Their Presence in Canada
     10.3 Europe
             10.3.1 Market Players Capitalizing on Opportunities in the European Next Generation Sequencing Market
                        10.3.1.1 Launch of New and Advanced Products and Services
                        10.3.1.2 Strategic Partnerships/Agreements/Collaborations to Develop Advanced Techniques
             10.3.2 Germany, U.K., and Belgium: Major Hubs for Scientific Research
             10.3.3 Growing Funding and Investments for NGS in Europe
     10.4 Asia-Pacific
             10.4.1 Growing Focus of Domestic and Multinational Players on APAC Market
                        10.4.1.1 Launch of Advanced NGS Products and Services
                        10.4.1.2 Partnerships/Collaborations/Agreements to Co-Develop Advanced NGS Products and Services
             10.4.2 Favorable Government Funding Scenario in Several Asia-Pacific Countries
             10.4.3 Growth in the Number of Conferences/Seminars/Training Programs in the Asia-Pacific Region
     10.5 Rest of the World (RoW)
             10.5.1 Focus of Key Market Players on Expanding Their Presence in the Rest of The World Region
             10.5.2 Growing Number of Workshops and Conferences
             10.5.3 Implementation of Favorable Initiatives By Public and Private Organizations

11 Competitive Landscape (Page No. - 141)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 New Product Launches and Product Enhancements
             11.3.2 Agreements, Partnerships, Collaborations, and Contracts
             11.3.3 Mergers and Acquisitions
             11.3.4 Geographic Expansions
             11.3.5 Other Developments

12 Company Profiles (Page No. - 149)
     12.1 Introduction
             12.1.1 Geographic Benchmarking
     12.2 Illumina, Inc.
     12.3 Thermo Fisher Scientific, Inc.
     12.4 Pacific Biosciences of California, Inc.
     12.5 Beijing Genomics Institute
     12.6 Qiagen N.V.
     12.7 454 Life Sciences Corporation (Roche Holding AG)
     12.8 Agilent Technologies, Inc.
     12.9 Eurofins Scientific
     12.10 Gatc Biotech AG
     12.11 Macrogen Inc.
     12.12 Oxford Nanopore Technologies, Ltd.
     12.13 Perkinelmer, Inc.

13 Appendix (Page No. - 202)
     13.1 Discussion Guide*
     13.2 Introducing RT: Real-Time Market Intelligence
     13.3 Available Customizations
     13.4 Related Reports


List of Tables (106 Tables)

Table 1 Next Generation Sequencing Market Size, By Products & Services, 2014–2021 (USD Million)
Table 2 Next Generation Sequencing Market Size, By Region, 2014–2021 (USD Million)
Table 3 Pre-Sequencing Products & Services Market Size, By Product, 2014–2021 (USD Million)
Table 4 Pre-Sequencing Products & Services Market Size, By Region, 2014–2021 (USD Million)
Table 5 DNA Fragmentation, End Repair, A-Tailing, & Size Selection Market Size,  By Region, 2014–2021 (USD Million)
Table 6 Library Preparation & Target Enrichment Market Size, By Region,  2014–2021 (USD Million)
Table 7 Quality Control Market Size, By Region, 2014–2021 (USD Million)
Table 8 NGS Instruments, Consumables, and Services Market Size, 2014–2021 (USD Million)
Table 9 NGS Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 10 Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 11 Services for Systems Market Size, By Region, 2014–2021 (USD Million)
Table 12 Illumina NGS Platforms Market Size, By Product, 2014–2021 (USD Million)
Table 13 Illumina NGS Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 14 Hiseq Series Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 15 Hiseq X Ten & Hiseq X Five Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 16 Miseq Series Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 17 Nextseq 500 Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 18 Thermo Fisher Scientific NGS Platforms Market Size, By Product,  2014–2021 (USD Million)
Table 19 Thermo Fisher Scientific NGS Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 20 Solid Series Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 21 ION PGM Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 22 ION Proton Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 23 ION S5 & S5 Xl Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 24 Pacific Biosciences NGS Platforms Market Size, By Product, 2014–2021 (USD Million)
Table 25 Pacific Biosciences NGS Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 26 Pacbio Rs Ii Platforms Market Size, By Region, 2014–2021 (USD Million)
Table 27 Sequel System Market Size, By Region, 2014–2021 (USD Million)
Table 28 Sequencing Services Market Size, By Application, 2014–2021 (USD Million)
Table 29 Sequencing Services Market Size, By Region, 2014–2021 (USD Million)
Table 30 Targeted Sequencing/Gene Panels Market Size, By Region, 2014–2021 (USD Million)
Table 31 RNA-Seq Market Size, By Region, 2014–2021 (USD Million)
Table 32 De Novo Sequencing Market Size, By Region, 2014–2021 (USD Million)
Table 33 Exome Sequencing Market Size, By Region, 2014–2021 (USD Million)
Table 34 Chip-Seq Market Size, By Region, 2014–2021 (USD Million)
Table 35 Whole-Genome Sequencing Market Size, By Region, 2014–2021 (USD Million)
Table 36 Methyl-Seq Market Size, By Region, 2014–2021 (USD Million)
Table 37 Other Applications Market Size, By Region, 2014–2021 (USD Million)
Table 38 NGS Bioinformatics Market Size, By Products & Services, 2014–2021 (USD Million)
Table 39 NGS Bioinformatics Market Size, By Region, 2014–2021 (USD Million)
Table 40 Data Analysis Software and Workbenches Market Size, By Region,  2014–2021 (USD Million)
Table 41 Data Analysis Services Market Size, By Region, 2014–2021 (USD Million)
Table 42 Next-Generation Sequencing Technologies, By Company
Table 43 Global Next-Generation Sequencing Market Size, By Technology, 2014–2021 (USD Million)
Table 44 Sequencing By Synthesis (SBS) Market Size, By Region, 2014–2021 (USD Million)
Table 45 ION Semiconductor Sequencing Market Size, By Region, 2014–2021 (USD Million)
Table 46 Sequencing By Ligation Market Size, By Region, 2014–2021 (USD Million)
Table 47 Pyrosequencing Market Size, By Region, 2014–2021 (USD Million)
Table 48 Single-Molecule Real-Time Sequencing (SMRT) Market Size, By Region,  2014–2021 (USD Million)
Table 49 Global Next Generation Sequencing Market, By Application, 2014–2021 (USD Million)
Table 50 Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 51 Drug Discovery Market Size, By Region, 2014-2021 (USD Million)
Table 52 Biomarker Discovery Market Size, By Region, 2014-2021 (USD Million)
Table 53 Personalized Medicine Market Size, By Region, 2014-2021 (USD Million)
Table 54 Agriculture and Animal Research Market Size, By Region, 2014-2021 (USD Million)
Table 55 Other Applications Market Size, By Region, 2014-2021 (USD Million)
Table 56 Global Next Generation Sequencing Market Size, By End User, 2014-2021 (USD Million)
Table 57 Research Centers, Academic/Government Institutes Market Size, By Region, 2014-2021 (USD Million)
Table 58 Hospitals & Clinics Market Size, By Region, 2014-2021 (USD Million)
Table 59 Pharmaceutical & Biotechnology Companies Market Size, By Region,  2014-2021 (USD Million)
Table 60 Other End Users Market Size, By Region, 2014-2021 (USD Million)
Table 61 Next Generation Sequencing Market Size, By Region, 2014–2021 (USD Million)
Table 62 North America: Next Generation Sequencing Market Size, By Products & Services, 2014–2021 (USD Million)
Table 63 North America: NGS Pre-Sequencing Products & Services Market Size,  By Product, 2014–2021 (USD Million)
Table 64 North America: Illumina NGS Platforms Market Size, 2014–2021 (USD Million)
Table 65 North America: Thermo Fisher Scientific NGS Platforms Market Size,  2014–2021 (USD Million)
Table 66 North America: Pacific Biosciences NGS Platforms Market Size, 2014–2021 (USD Million)
Table 67 North America: Sequencing Services Market Size, By Application, 2014–2021 (USD Million)
Table 68 North America: NGS Bioinformatics Market Size, By Products & Services, 2014–2021 (USD Million)
Table 69 North America: Next Generation Sequencing Market Size, By Technology, 2014–2021 (USD Million)
Table 70 North America: Next Generation Sequencing Market Size, By Application, 2014–2021 (USD Million)
Table 71 North America: Next Generation Sequencing Market Size, By End User, 2014–2021 (USD Million)
Table 72 Europe: Next Generation Sequencing Market Size, By Products & Services, 2014–2021 (USD Million)
Table 73 Europe: NGS Pre-Sequencing Products & Services Market Size, By Product, 2014–2021 (USD Million)
Table 74 Europe: Illumina NGS Platforms Market Size, 2014–2021 (USD Million)
Table 75 Europe: Thermo Fisher Scientific NGS Platforms Market Size, 2014–2021 (USD Million)
Table 76 Europe: Pacific Biosciences NGS Platforms Market Size, 2014–2021 (USD Million)
Table 77 Europe: Sequencing Services Market Size, By Application, 2014–2021 (USD Million)
Table 78 Europe: NGS Bioinformatics Market Size, By Products & Services,  2014–2021 (USD Million)
Table 79 Europe: Next Generation Sequencing Market Size, By Technology, 2014–2021 (USD Million)
Table 80 Europe: Next Generation Sequencing Market Size, By Application, 2014–2021 (USD Million)
Table 81 Europe: Next Generation Sequencing Market Size, By End User, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Next Generation Sequencing Market Size, By Products & Services, 2014–2021 (USD Million)
Table 83 Asia-Pacific: NGS Pre-Sequencing Products & Services Market Size, By Product, 2014–2021 (USD Million)
Table 84 Asia-Pacific: Illumina NGS Platforms Market Size, 2014–2021 (USD Million)
Table 85 Asia-Pacific: Thermo Fisher Scientific NGS Platforms Market Size,  2014–2021 (USD Million)
Table 86 Asia-Pacific: Pacific Biosciences NGS Platforms Market Size, 2014–2021 (USD Million)
Table 87 Asia-Pacific: Sequencing Services Market Size, By Application, 2014–2021 (USD Million)
Table 88 Asia-Pacific: NGS Bioinformatics Market Size, By Products & Services,  2014–2021 (USD Million)
Table 89 Asia-Pacific: Next Generation Sequencing Market Size, By Technology, 2014–2021 (USD Million)
Table 90 Asia-Pacific: Next Generation Sequencing Market Size, By Application, 2014–2021 (USD Million)
Table 91 Asia-Pacific: Next Generation Sequencing Market Size, By End User, 2014–2021 (USD Million)
Table 92 RoW: Next Generation Sequencing Market Size, By Products & Services, 2014–2021 (USD Million)
Table 93 RoW: NGS Pre-Sequencing Products & Services Market Size, By Product, 2014–2021 (USD Million)
Table 94 RoW: Illumina NGS Platforms Market Size, 2014–2021 (USD Million)
Table 95 RoW: Thermo Fisher Scientific NGS Platforms Market Size, 2014–2021 (USD Million)
Table 96 RoW: Pacific Biosciences NGS Platforms Market Size, 2014–2021 (USD Million)
Table 97 RoW: Sequencing Services Market Size, By Application, 2014–2021 (USD Million)
Table 98 RoW: NGS Bioinformatics Market Size, By Products & Services, 2014–2021 (USD Million)
Table 99 RoW: Next Generation Sequencing Market Size, By Technology, 2014–2021 (USD Million)
Table 100 RoW: Next Generation Sequencing Market Size, By Application, 2014–2021 (USD Million)
Table 101 RoW: Next Generation Sequencing Market Size, By End User, 2014–2021 (USD Million)
Table 102 Top 5 New Product Launches and Product Enhancements, 2013–2015
Table 103 Top 5 Agreements, Partnerships, Collaborations, and Contracts,  2013–2015
Table 104 Top Mergers and Acquisitions, 2013–2015
Table 105 Top Geographic Expansions, 2013–2015
Table 106 Top 5 Other Developments, 2013–2015


List of Figures (44 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 NGS Market: Bottom-Up Approach
Figure 4 NGS Market: Top-Down Approach
Figure 5 NGS Market: Data Triangulation
Figure 6 Global NGS Market, By Application, 2016 (USD Million)
Figure 7 Global NGS Platforms Market, 2016 vs 2021
Figure 8 Global NGS Market, By Region, 2016 (USD Million)
Figure 9 Attractive Growth Opportunities in the NGS Market
Figure 10 Pre-Sequencing Products & Services Segment is Expected to Gain Market Share in 2021
Figure 11 Methyl-Seq and De Novo Sequencing is Expected to Grow at  Higher CAGR From 2016 to 2021
Figure 12 Sequencing By Synthesis to Command the Largest Share of the NGS Technologies in 2016
Figure 13 Next Generation Sequencing Market, By Products & Services
Figure 14 Next Generation Sequencing Market, By Technology
Figure 15 Next Generation Sequencing Market, By Application
Figure 16 Next Generation Sequencing Market, By End User
Figure 17 Next Generation Sequencing Market Dynamics
Figure 18 List of Sequencing Platforms Launched By Market Players in 2015-2016
Figure 19 New Market Players and Their Sequencing Platforms
Figure 20 Technological Advancements to Increase Adoption of NGS Platforms
Figure 21 Lack of Skilled Technicians Hinders the NGS Market Growth
Figure 22 Personalized Medicine & Biomarker Discovery Open Avenues for the Growth of NGS Market
Figure 23 Data Storage and Interpretation are Major Concerns of NGS Market
Figure 24 Major Acquisitions in the NGS Market
Figure 25 SMRT Sequencing is Expected to Grow at the Highest CAGR During 2016 to 2021
Figure 26 Diagnostics Segment to Hold Largest Share in the Market During 2016-2021
Figure 27 Hospitals & Clinics End User Segment to Witness Highest Growth During the Forecast Period
Figure 28 Global NGS Market Overview
Figure 29 North American NGS Market Snapshot
Figure 30 European NGS Market Snapshot
Figure 31 Asia-Pacific NGS Market Snapshot
Figure 32 RoW NGS Market Snapshot
Figure 33 Leading Market Players Adopted Both Organic and Inorganic Growth Strategies Over the Last Three Years (2013–2015)
Figure 34 Global NGS Market Share Analysis, By Key Player, 2015
Figure 35 Geographic Revenue Mix of the Top Four Market Players* (2014)
Figure 36 Illumina, Inc.: Company Snapshot
Figure 37 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 38 Pacific Biosciences of California, Inc.: Company Snapshot
Figure 39 Qiagen N.V.: Company Snapshot
Figure 40 Roche Holding AG: Company Snapshot
Figure 41 Agilent Technologies, Inc.: Company Snapshot
Figure 42 Eurofins Scientific: Company Snapshot
Figure 43 Macrogen Inc.: Company Snapshot
Figure 44 Perkinelmer, Inc.: Company Snapshot

The next generation sequencing market is expected to reach USD 10,371.1 Million by 2021 from USD 4,031.7 Million in 2016, at a CAGR of 20.8% between 2016 and 2021. Technological advancements in NGS products, increasing applications of NGS, entry of new market players, and increasing partnerships & collaborations among market players majorly drives the growth of the next generation sequencing market. Other growth factors include growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders.

However, accuracy & standardization concerns in diagnostic testing, lack of skilled professionals, and ethical & legal issues related to NGS are some of the key factors restraining the growth of this market. In addition to this, challenges associated with interpretation of complex data from NGS platforms and storage of sequencing data also limits the growth of the NGS market.

This report broadly segments the global next generation sequencing market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The pre-sequencing products & services segment if further categorized into DNA fragmentation. End repair, A-tailing, & size selection; library preparation & target enrichment; and quality control. The NGS platforms segment is sub-segmented into HiSeq Series, MiSeq Series, HiSeq X Ten & X Five, NextSeq500, Ion PGM, ION Proton, Ion S5 & S5 XL, PacBioRS II, and Sequel System. Based on applications, the sequencing services market is segmented into targeted sequencing, whole-genome sequencing, exome sequencing, RNA-Seq, De novo sequencing, Methyl-Seq, and ChiP-seq. The consumables segment is expected to command the major share of the next generation sequencing market, by products& services, in 2016.

On the basis of technology, the global next generation sequencing market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, sequencing by ligation (SBL), pyrosequencing, and single-molecule real-time (SMRT) sequencing. In 2016, the SBS technology is expected to account for the largest share of the global NGS market, by technology.

Based on application, the global NGS market is segmented into diagnostics, drug discovery, biomarker discovery, personalized medicine, agriculture & animal research, and others (marine, forensic, & biofuel research). In 2016, the diagnostics application segment is expected to account for the largest share of the NGS market, by application.

The end users of next generation sequencing market include research centers & academic/government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others (non-profit organizations & agrigenomics organizations). In 2016, the research centers & academic/government institutes end user segment is expected to account for the largest share of the NGS market, by end user.

This report covers the NGS market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to command the largest share of the global next generation sequencing market. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to improving healthcare infrastructure and favorable government initiatives in this region.

Major players in the global NGS market include Illumina, Inc. (U.S.); Thermo Fisher Scientific, Inc. (U.S.); Pacific Biosciences of California, Inc. (U.S.); Roche Holding AG (Switzerland); QIAGEN N. V. (Germany); BGI (China), Macrogen Inc. (South Korea); Eurofins Scientific (Luxembourg); and Oxford Nanopore Technologies, Ltd. (U.K.).

Available Customizations Title

Client Customization Problem Statement : Global Market Forecasting of NGS Installations

Solution Provided:
In this customization, MnM developed insights beyond the report covering market sizing and forecast of cumulative instal....
In this customization, MnM developed insights beyond the report covering market sizing and forecast of cumulative installation of NGS platforms at regional level. It also focused on finding out locations of NGS platform installation across all major regions. The market was estimated at all levels and was cross validated through primary interviews.
less...
Request Customization
 more...

Client Consult Problem Statement : MnM’s client was interested in the U.S. NGS services market and its sub-segments. Additionally, the client also wanted to understand the guidelines for regulations and payment challenges involved with NGS services in the U.S. along with estimation and forecast of high-growth segments of the market.

Solution Provided:

1. Methodology Adopted by MnM :

Both, top-down and bottom-up approaches were used to de....

1. Methodology Adopted by MnM :

Both, top-down and bottom-up approaches were used to derive the data. MnM utilized authentic secondary sources (government websites, associations and groups, annual reports of companies, SEC filings, corporate presentations) along with MnM Repository to gain insights, both quantitative and qualitative, into the market. MnM then conducted multi-level, qualitative & quantitative study with a constructed sample of mid to senior level management executives and industry professionals to understand key parameters influencing the market.  At every level the estimates were further verified with industry experts.

2. Actual Solution Provided:

   • Identified companies that play major role in providing NGS services 
   • Competitive landscape of companies with existing and estimated market share analysis
   • Identified potential challenges in shipping genome sequencing samples to the U.S.
   • Strategic recommendation related to focused services and market
   • Provided information on guidelines for regulations and payment challenges
   • Analyzed the opportunities in the market for the client by identifying the high-growth segments

Value Delivered:

Client could identify the crucial end-users to enhance its business across the segments and geographies. Additionally, the study helped client to restructure its services pricing, with the current and future price trend.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo